Collectively, these transcriptomic findings suggest that SM102 LNPs-Il1rn mRNA exerts dual therapeutic effects in tendinitis by targeting IL-1 signaling—simultaneously inhibiting inflammatory cascades and activating collagen-driven ECM restoration. Here, IL1RN is linked to tendinitis.